Ultimate magazine theme for WordPress.

Terrific journalism on a troubling subject |

Posted By

  • Gary 2017

Gary Schwitzer is the founder and writer of HealthNewsReview. He has coated well being care information nearly completely since 1973. Right here is his on-line bio.  He tweets as @garyschwitzer or as @HealthNewsRevu.

Terrific journalism on a troubling subject |Charles Piller writes in Science, “Blots On a Discipline? A neuroscience picture sleuth finds indicators of fabrication in scores of Alzheimer’s articles, threatening a reigning idea of the illness.

It’s a terrific piece of journalism that raises questions on a protracted unproven idea about Alzheimer’s illness.  The brand new questions are fueled by allegations of fraud in key analysis.  One key quote:

“The instant, apparent injury is wasted NIH funding and wasted pondering within the area as a result of persons are utilizing these outcomes as a place to begin for their very own experiments,” says Stanford College neuroscientist Thomas Südhof, a Nobel laureate and professional on Alzheimer’s and associated situations.

Jeremy Olson of the Star Tribune put the brand new allegations within the context of a “difficult legacy” on the College of Minnesota Medical Faculty.  Excerpt:

Regardless of a outstanding historical past of life-saving innovations and surgical accomplishments, the U additionally has a legacy of analysis stars being implicated in scandals.

The late Dr. S. Charles Schulz stepped down as U psychiatry chair in 2015 amid claims by a grieving household that their son, who died by suicide, was coercively recruited right into a schizophrenia drug trial.

Duplicated photographs and errors compelled the correction of a 2002 Nature examine, led by Dr. Catherine Verfaillie, claiming that sure grownup stem cells possessed versatile skills to develop and develop different cell varieties.

The late Dr. John Najarian was a pioneer in organ transplantation who elevated the U’s international profile, however he confronted federal sanctions within the Nineteen Nineties associated to illicit gross sales of an experimental anti-rejection medicine that improved transplant outcomes.

Comments are closed.